Hap Trading, LLC Halozyme Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $380,970 - $492,660	-10,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$31.97 - $41.06 $326,094 - $418,812	10,200 New	10,200 $10,000
Q1 2020 May 08, 2020	SELL	$13.9 - $21.83 $423,950 - $665,815	-30,500 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$14.93 - $19.53 $129,891 - $169,911	8,700 Added 39.91%	30,500 $45,000
Q3 2019 Nov 12, 2019	BUY	$15.2 - $17.69 $44,080 - $51,301	2,900 Added 15.34%	21,800 $35,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $101,775 - $119,094	6,900 Added 57.5%	18,900 $23,000
Q1 2019 May 10, 2019	BUY	$13.94 - $17.58 $18,122 - $22,853	1,300 Added 12.15%	12,000 $15,000
Q4 2018 Feb 12, 2019	BUY	$13.33 - $18.66 $142,631 - $199,662	10,700 New	10,700 $2,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.